The novel approach for cancer therapy:by skin delivery of IDO shRNA
博士 === 國立成功大學 === 基礎醫學研究所 === 97 === Indoleamine 2,3-dioxygenase (IDO) is a rate-limiting enzyme of tryptophan degradating pathway and a negative immunoregulatory molecule of dendritic cells. IDO-expressing dendritic cells suppress proliferation and activation of effector T cells and induce prolifer...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2009
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/49566124315074026533 |